Pure Global

Aoshi subtilin 0.05 unit identification paper ingot - Taiwan Registration d574c699a44cb313c939ab2f963af141

Access comprehensive regulatory information for Aoshi subtilin 0.05 unit identification paper ingot in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d574c699a44cb313c939ab2f963af141 and manufactured by OXOID LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d574c699a44cb313c939ab2f963af141
Registration Details
Taiwan FDA Registration: d574c699a44cb313c939ab2f963af141
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Aoshi subtilin 0.05 unit identification paper ingot
TW: ๅ‚ฒไธ– ๆžฏ่‰่Œ็ด 0.05ๅ–ฎไฝ้‘‘ๅฎš็”จ็ด™้Œ 
Risk Class 1
Cancelled

Registration Details

d574c699a44cb313c939ab2f963af141

DHA04400307806

Company Information

United Kingdom

Product Details

Distinguish between Lancefield group A streptococci and other ฮฒ hemolytic streptococci.

C Immunology and microbiology

C.2660 ๅพฎ็”Ÿ็‰ฉ้‘‘ๅˆฅๅŠๆธฌๅฎšๅ™จๆ

import

Dates and Status

Mar 22, 2006

Mar 22, 2011

Nov 08, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ